CRH Medical Corp (NASDAQ:CRHM) shares saw unusually-strong trading volume on Wednesday . Approximately 119,493 shares were traded during trading, a decline of 10% from the previous session’s volume of 133,110 shares.The stock last traded at $4.00 and had previously closed at $4.12.

Several analysts have recently weighed in on CRHM shares. Canaccord Genuity reiterated a “buy” rating on shares of CRH Medical Corp in a research report on Monday. Zacks Investment Research upgraded shares of CRH Medical Corp from a “hold” rating to a “buy” rating and set a $3.75 target price on the stock in a research report on Monday, June 6th.

The firm’s 50 day moving average is $3.14 and its 200 day moving average is $2.95.

CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.